Literature DB >> 2983558

Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation.

J M Seddon, E S Gragoudas, D M Albert, C C Hsieh, L Polivogianis, G R Friedenberg.   

Abstract

UNLABELLED: We compared survival experiences for three groups with uveal melanoma: (1) 120 patients treated by proton beam irradiation from 1975 to 1981; (2) 235 patients treated by enucleation from 1953 to 1973 (enucleation group 1); and (3) 161 patients treated by enucleation from 1975 to 1981 (enucleation group 2). The following variables were predictive of melanoma-related deaths. TREATMENT: rate ratio (ratio of the rate of death for one category of the variable relative to the rate of death for another category) of 6.32 (95% confidence interval 1.70 to 23.51) for enucleation group 1 vs proton beam, 3.06 (0.81 to 11.54) for enucleation group 2 vs proton beam, and 2.07 (1.05 to 4.07) for enucleation group 1 vs enucleation group 2. Size: rate ratio of 3.61 (1.51 to 8.64) for large (16+ mm) vs small (less than 11 mm) tumors. LOCATION: rate ratio of 3.19 (1.56 to 6.53) for tumors anterior vs posterior to the equator. When death from all causes was evaluated as the outcome, the estimated rate ratios were similar. When melanoma metastasis was evaluated as the outcome, the estimated rate ratios were reduced in magnitude.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983558     DOI: 10.1016/0002-9394(85)90357-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Experimental study on the fractionation schedule for proton irradiation of uveal melanoma.

Authors:  G Wollensak; L Zografos; C Perret; E Egger; H Fritz-Niggli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups.

Authors:  J J Augsburger; J W Gamel; J A Shields
Journal:  Trans Am Ophthalmol Soc       Date:  1989

3.  Uveal melanoma management.

Authors:  D H Char; E S Gragoudas; T L Phillips
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

4.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

5.  Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.

Authors:  Bum-Sup Jang; Ji Hyun Chang; Sohee Oh; Yu Jin Lim; Il Han Kim
Journal:  Strahlenther Onkol       Date:  2017-09-06       Impact factor: 3.621

6.  Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy.

Authors:  D H Char; S Kroll; J M Quivey; J Castro
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

7.  Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival.

Authors:  P De Potter; C L Shields; J A Shields; J R Cater; D J Tardio
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

8.  Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results.

Authors:  W A Manschot; R Van Strik
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

9.  Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature.

Authors:  Yolanda Piña; Colleen M Cebulla; Timothy G Murray; Armando Alegret; Sander R Dubovy; Hinda Boutrid; William Feuer; Lejla Mutapcic; Maria-Elena Jockovich
Journal:  Ophthalmic Res       Date:  2009-03-26       Impact factor: 2.892

10.  Transvitreal retinochoroidal biopsy.

Authors:  E Scherfig; J U Prause; O A Jensen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.